Newsfeeds - Spark Newswire

1 minute read

HC Wainwright & Co. Initiates Coverage On SQZ Biotechnologies with Buy Rating, Announces Price Target of $10

Today, 7:47 AM

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on SQZ Biotechnologies (NYSE:SQZ) with a Buy rating and announces Price Target of $10.

SQZ

1 minute read

SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ AAC Platform’s Potential As An Effective Red Blood Cell-Derived Immunotherapy

By Benzinga Newsdesk

Today, 7:47 AM

Activating Antigen Carriers (AACs) Shown Preclinically to Activate CD8 T Cells, Increase Their Tumor Infiltration and Drive Tumor Killing Demonstrated Improved Efficacy of AAC Therapy Through Combination with

SQZ

56 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 7:47 AM

On Thursday, 1076 companies hit new 52-week lows.

$APE

6 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 7:47 AM

On Monday, 92 companies set new 52-week lows.

ABVC

1 minute read

News

SQZ Biotechnologies Announces Generation Of Dopaminergic Neurons From Human Pluripotent Stem Cells Through Single-Step Delivery Of Six Cell-Fate Encoding RNAs

By Benzinga Newsdesk

Today, 7:47 AM

Pre-Clinical Research Could Lead to Rapid Development of Dopamine-Producing Neurons; Part of Company's NIH-Funded Program Seeking Scalable Cell Replacement Therapy Approaches for Parkinson's Disease Use of

SQZ

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For May 25, 2022

By Benzinga Insights

Today, 7:47 AM

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

ALE

4 minute read

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

By Vandana Singh

Today, 7:47 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 7:47 AM

Wednesday's session saw 784 companies set new 52-week lows.

AADI

33 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 7:47 AM

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

10 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 7:47 AM

On Wednesday, 160 companies hit new 52-week lows.

ACLX